Chemotherapy and Radiation Therapy as Compared with Radiation Therapy in Stage III Non-Small-Cell Cancer

Abstract
The clinical trial reported by Dillman et al. (Oct. 4 issue)1 and the accompanying editorial by Tannock and Boyer2 raise some interesting issues of cost and benefit in cancer treatment. We would like to counsel considerable caution in interpreting the results of the study.